Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Apex Biotechnology Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Apex Biotechnology Corp (1733-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 11 $25.00

Apex Biotechnology Corp. (1733) - Financial Analysis Review

Apex Biotechnology Corp. (1733) - Financial Analysis Review Summary Apex Biotechnology Corp. (ApexBio) is a medical device co...

14 Oct 2016 GlobalData 31 $300.00

Wright Investors Service Comprehensive Report for Apex Biotechnology Corporation

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

19 Sep 2016 Wright Reports 65 $75.00

Apex Biotechnology Corp. (1733) - Financial Analysis Review

Apex Biotechnology Corp. (1733) - Financial Analysis Review Summary Apex Biotechnology Corp. (ApexBio) is a medical device co...

12 Sep 2016 GlobalData 31 $300.00

Will Apex Biotechnology Corp. Perform Long Term?

07 Sep 2016 Sadif Analytics Prime 12 $25.00

Apex Biotechnology Corp.: Upgraded to Good

31 Aug 2016 Sadif Analytics Prime 3 $10.00

ApexBio (1733 TT): Fairly Valued

In recent years, the BGM market has experienced a major change. With the aging trend and the growing population of chronic di...

02 Aug 2016 MasterLink Securities Corporation 5 $46.00

五鼎 (1733):公司趨勢正向,目前評價合理,營運尚待重啟動能

產業需求仍正向,等待成長時機,下調買進至中立評等:近年血糖檢測廠商丕變,然於人口高齡化與慢性病人口成長趨勢下,整體需求仍在,國內廠商亦具成長機會。產業需求仍在,且五鼎皆能配合歐洲客戶需求,生產出符合最新法規要求之新產品,惟目前評價合理,建議待客戶標案...

29 Jul 2016 MasterLink Securities Corporation 4 $23.00

Is The Recovery in Apex Biotechnology Corp. Too Much, Too Soon?

08 Jun 2016 Sadif Analytics Prime 12 $25.00